We want to inform our patients and the community about an important update regarding Saxenda® (liraglutide injection).
The manufacturer has announced that the production and commercial availability of Saxenda® will be discontinued as of March 2026. It is important to note that this decision is not due to any safety or quality concerns with the medication.
Upcoming Shortage Expected
In addition to the planned discontinuation, a shortage of Saxenda® is anticipated in Canada starting as early as October 2025 or sooner. While patients can currently continue their treatment and fill existing prescriptions, it’s important to begin planning for an alternative weight management option as supplies may become limited.
What Patients Should Do
If you are currently using Saxenda®:
- Do not stop your medication abruptly.
- Speak with your healthcare provider or pharmacist as soon as possible to explore alternative options.
- Proactive planning can help ensure a smooth transition and avoid any disruptions in your weight management program.
How Centrum Pharmacy Can Help
At Centrum Pharmacy, our pharmacists are here to support you through this transition. We can:
- Review your current treatment.
- Assess your individual needs.
- Collaborate with your physician to recommend safe and effective alternative treatments.
- Provide guidance and education on the available options to help you maintain your health and wellness.
Don’t wait for shortages to impact your treatment — contact us at Centrum Pharmacy today to schedule a consultation and ensure you have a plan in place.
Disclaimer: The medical information on this site is provided as an information resource only and is not to be used or relied on for any diagnostic or treatment purposes. This information does not substitute for professional diagnosis and treatment. Please do not initiate, modify, or discontinue any treatment, medication, or supplement solely based on this information. Always seek the advice of your healthcare provider first. Full Disclaimer.
